The Glucagon-Like Peptide-1 Analog Liraglutide Suppresses Ghrelin and Controls Diabetes in a Patient With Prader-Willi Syndrome

Endocrine Journal - Japan
doi 10.1507/endocrj.ej12-0074
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Endocrine Society

Related search

A Glucagon-Like Peptide-1 Analog, Liraglutide, Ameliorates Endothelial Dysfunction Through miRNAs to Inhibit Apoptosis in Rats

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2019English

Intraoperative Adrenal Insufficiency in a Patient With Prader-Willi Syndrome

Journal of Clinical Medicine Research
2012English

Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Inhibits Endothelial Cell Inflammation Through a Calcium and AMPK Dependent Mechanism

PLoS ONE
Multidisciplinary
2014English

Prader-Willi Syndrome

2020English

Schaaf-Yang Syndrome Shows a Prader-Willi Syndrome-Like Phenotype During Infancy

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2019English

Food Preferences in Prader-Willi Syndrome, Normal Weight and Obese Controls

International Journal of Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
1997English

Prader-Willi Syndrome

English

Deletion of the SIM1 Gene (6q16.2) in a Patient With a Prader-Willi-Like Phenotype

Journal of Medical Genetics
Genetics
2002English

Dexamethasone Suppressible Hypergonadotropism in an Adolescent Patient With Prader-Willi Syndrome.

Endocrinologia Japonica
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy